Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview Article

Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases

Pablo Engel, José A. Gómez-Puerta, Manuel Ramos-Casals, Francisco Lozano and Xavier Bosch
David R. Sibley, ASSOCIATE EDITOR
Pharmacological Reviews March 2011, 63 (1) 127-156; DOI: https://doi.org/10.1124/pr.109.002006
Pablo Engel
Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain (P.E., F.L.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (P.E., M.R.-C., F.L., X.B.); Arthritis Unit, Department of Rheumatology (J.A.G.-P.), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases (M.R.-C.), Department of Immunology (F.L.), and Department of Internal Medicine (X.B.), Hospital Clínic Universitari de Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José A. Gómez-Puerta
Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain (P.E., F.L.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (P.E., M.R.-C., F.L., X.B.); Arthritis Unit, Department of Rheumatology (J.A.G.-P.), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases (M.R.-C.), Department of Immunology (F.L.), and Department of Internal Medicine (X.B.), Hospital Clínic Universitari de Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Ramos-Casals
Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain (P.E., F.L.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (P.E., M.R.-C., F.L., X.B.); Arthritis Unit, Department of Rheumatology (J.A.G.-P.), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases (M.R.-C.), Department of Immunology (F.L.), and Department of Internal Medicine (X.B.), Hospital Clínic Universitari de Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Lozano
Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain (P.E., F.L.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (P.E., M.R.-C., F.L., X.B.); Arthritis Unit, Department of Rheumatology (J.A.G.-P.), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases (M.R.-C.), Department of Immunology (F.L.), and Department of Internal Medicine (X.B.), Hospital Clínic Universitari de Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Bosch
Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain (P.E., F.L.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (P.E., M.R.-C., F.L., X.B.); Arthritis Unit, Department of Rheumatology (J.A.G.-P.), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases (M.R.-C.), Department of Immunology (F.L.), and Department of Internal Medicine (X.B.), Hospital Clínic Universitari de Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Sibley
Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain (P.E., F.L.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (P.E., M.R.-C., F.L., X.B.); Arthritis Unit, Department of Rheumatology (J.A.G.-P.), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases (M.R.-C.), Department of Immunology (F.L.), and Department of Internal Medicine (X.B.), Hospital Clínic Universitari de Barcelona, Barcelona, Spain
Roles: ASSOCIATE EDITOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 63 no. 1 127-156
DOI 
https://doi.org/10.1124/pr.109.002006
PubMed 
21245206

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online February 15, 2011.

Article Versions

  • Earlier version (January 18, 2011 - 07:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Pablo Engel,
  2. José A. Gómez-Puerta,
  3. Manuel Ramos-Casals,
  4. Francisco Lozano, and
  5. Xavier Bosch
  1. Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain (P.E., F.L.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (P.E., M.R.-C., F.L., X.B.); Arthritis Unit, Department of Rheumatology (J.A.G.-P.), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases (M.R.-C.), Department of Immunology (F.L.), and Department of Internal Medicine (X.B.), Hospital Clínic Universitari de Barcelona, Barcelona, Spain
  1. David R. Sibley, ASSOCIATE EDITOR
  1. Address correspondence to:
    Dr. Xavier Bosch, Department of Internal Medicine, Hospital Clínic, University of Barcelona, Barcelona, Spain. E-mail: xavbosch{at}clinic.ub.es
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2018 to September 2023

AbstractFullPdf
Jan 2018310124
Feb 2018711729
Mar 2018712146
Apr 2018633926
May 201829226
Jun 201817617
Jul 201827322
Aug 201806316
Sep 201816823
Oct 201828227
Nov 201827715
Dec 2018562713
Jan 20199688
Feb 20196923
Mar 201973137
Apr 20197143
May 20196764
Jun 20197731
Jul 20192992
Aug 20193821
Oct 20192350
Nov 20195668
Dec 20195631
Jan 20204532
Feb 20201621
Mar 20202784
May 20204031
Jun 20206452
Jul 20204702
Aug 20201526
Sep 20201932
Oct 20207561
Nov 20206921
Dec 20206021
Jan 20213053
Feb 20212243
Mar 20214972
Apr 20216011
May 20212273
Jun 20212354
Jul 20213710
Aug 20217250
Sep 20214191
Oct 20215140
Nov 20215021
Dec 20215410
Jan 20225362
Feb 202249155
Mar 20222741
Apr 20228851
May 20225320
Jun 20224310
Jul 20228751
Aug 20224841
Sep 20225642
Oct 20223446
Nov 20226953
Dec 20226654
Jan 20234443
Feb 20235662
Mar 20233521
Apr 20231643
May 20233487
Jun 20232541
Jul 20237326
Aug 20233024
Sep 20233151

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 63 (1)
Pharmacological Reviews
Vol. 63, Issue 1
1 Mar 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleReview Article

Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases

Pablo Engel, José A. Gómez-Puerta, Manuel Ramos-Casals, Francisco Lozano and Xavier Bosch
Pharmacological Reviews March 1, 2011, 63 (1) 127-156; DOI: https://doi.org/10.1124/pr.109.002006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticleReview Article

Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases

Pablo Engel, José A. Gómez-Puerta, Manuel Ramos-Casals, Francisco Lozano and Xavier Bosch
Pharmacological Reviews March 1, 2011, 63 (1) 127-156; DOI: https://doi.org/10.1124/pr.109.002006
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. B-Cell Biology
    • III. B-Cell Pathogenesis
    • IV. Targeting B Cells
    • V. Safety of B-Cell-Depletion Agents
    • VI. Future Directions and Conclusions
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PROKINETICIN RECEPTORS AS THERAPEUTIC TARGETS
  • ASO and siRNA drugs for systemic diseases of liver origin
  • β-Arrestins: Structure, Function, and Physiology
Show more Review Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics